drugset / Trial / NCT06170593

Intralesional Injections of Triamcinolone for Acne Vulgaris

NCT06170593

Completed 20 enrolled ACOM Labs
NaSingle-groupOpen-labelTreatment

Summary

This proof-of-concept study seeks to investigate the safety of intralesional injections of triamcinolone for acne vulgaris lesions using an Intradermal Needle Adapter.

Timeline

Start
2022-11-15
Primary completion
2023-01-31
Completion
2023-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Other / unclassified 0.1 ml Other
Subject Triamcinolone Other / unclassified 1 % Other

Indications